These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23867631)

  • 1. Induction of pulmonary hypertensive changes by extracellular vesicles from monocrotaline-treated mice.
    Aliotta JM; Pereira M; Amaral A; Sorokina A; Igbinoba Z; Hasslinger A; El-Bizri R; Rounds SI; Quesenberry PJ; Klinger JR
    Cardiovasc Res; 2013 Dec; 100(3):354-62. PubMed ID: 23867631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury Model.
    Aliotta JM; Pereira M; Wen S; Dooner MS; Del Tatto M; Papa E; Cheng Y; Goldberg L; Ventetuolo CE; Liang O; Klinger JR; Quesenberry PJ
    Stem Cells Transl Med; 2017 Jul; 6(7):1595-1606. PubMed ID: 28474513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice.
    Aliotta JM; Pereira M; Wen S; Dooner MS; Del Tatto M; Papa E; Goldberg LR; Baird GL; Ventetuolo CE; Quesenberry PJ; Klinger JR
    Cardiovasc Res; 2016 Jun; 110(3):319-30. PubMed ID: 26980205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marrow cell infusion attenuates vascular remodeling in a murine model of monocrotaline-induced pulmonary hypertension.
    Aliotta JM; Keaney PJ; Warburton RR; DelTatto M; Dooner MS; Passero MA; Quesenberry PJ; Klinger JR
    Stem Cells Dev; 2009 Jun; 18(5):773-82. PubMed ID: 19072290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats.
    Yip HK; Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Fu M
    Crit Care Med; 2008 Mar; 36(3):873-80. PubMed ID: 18431275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice.
    Li L; Wei C; Kim IK; Janssen-Heininger Y; Gupta S
    Hypertension; 2014 Jun; 63(6):1260-9. PubMed ID: 24614212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
    Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ
    Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles: small but strong.
    Martínez MC
    Cardiovasc Res; 2013 Dec; 100(3):350-1. PubMed ID: 24148897
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline.
    Dias-Neto M; Luísa-Neves A; Pinho S; Gonçalves N; Mendes M; Eloy C; Lopes JM; Gonçalves D; Ferreira-Pinto M; Leite-Moreira AF; Henriques-Coelho T
    Pediatr Cardiol; 2015 Jun; 36(5):1000-13. PubMed ID: 25608696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Marrow-Derived Endothelial Progenitor Cells Contribute to Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibition of Store-Operated Ca
    Miao R; Wan J; Liu J; Yuan JX; Wang J; Xie W; Zhai Z; Wang C
    Biomed Res Int; 2018; 2018():4892349. PubMed ID: 30320134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse contribution of bone marrow-derived late-outgrowth endothelial progenitor cells to vascular repair under pulmonary arterial hypertension and arterial neointimal formation.
    Ikutomi M; Sahara M; Nakajima T; Minami Y; Morita T; Hirata Y; Komuro I; Nakamura F; Sata M
    J Mol Cell Cardiol; 2015 Sep; 86():121-35. PubMed ID: 26231083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble guanylate cyclase stimulator, trans-4-methoxy-β-nitrostyrene, has a beneficial effect in monocrotaline-induced pulmonary arterial hypertension in rats.
    Gonzaga-Costa K; Vasconcelos-Silva AA; Rodrigues-Silva MJ; Rebouça CDSM; Duarte GP; Borges RS; Magalhães PJC; Lahlou S
    Eur J Pharmacol; 2021 Apr; 897():173948. PubMed ID: 33609564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
    Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
    Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension is ameliorated in mice deficient in thrombin-activatable fibrinolysis inhibitor.
    Qin L; D'Alessandro-Gabazza CN; Aoki S; Gil-Bernabe P; Yano Y; Takagi T; Boveda-Ruiz D; Ramirez Marmol AY; San Martin Montenegro VT; Toda M; Miyake Y; Taguchi O; Takei Y; Morser J; Gabazza EC
    J Thromb Haemost; 2010 Apr; 8(4):808-16. PubMed ID: 20088932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice.
    Raoul W; Wagner-Ballon O; Saber G; Hulin A; Marcos E; Giraudier S; Vainchenker W; Adnot S; Eddahibi S; Maitre B
    Respir Res; 2007 Jan; 8(1):8. PubMed ID: 17263874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension.
    Spees JL; Whitney MJ; Sullivan DE; Lasky JA; Laboy M; Ylostalo J; Prockop DJ
    FASEB J; 2008 Apr; 22(4):1226-36. PubMed ID: 18032636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial-like progenitor cells engineered to produce prostacyclin rescue monocrotaline-induced pulmonary arterial hypertension and provide right ventricle benefits.
    Zhou L; Chen Z; Vanderslice P; So SP; Ruan KH; Willerson JT; Dixon RA
    Circulation; 2013 Aug; 128(9):982-94. PubMed ID: 23841984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.
    Tofovic SP; Salah EM; Mady HH; Jackson EK; Melhem MF
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):430-7. PubMed ID: 16160593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.